Chapter 128: Cooperation with Liu Guosong

Time slowly arrived at ten o'clock in the morning sharp.

A handsome and tall figure walked onto the podium, instantly attracting everyone's attention.

"Hello everyone, I am Su Xin."

"I welcome all media friends and guests to the first press conference of Tianqi Pharmaceutical Company."

Su Xin smiled and greeted everyone, then pressed the remote control in his hand.

The large screen behind him lit up immediately, displaying the name and logo of Tianqi Pharmaceutical Company.

"As you all know, I have never liked to talk nonsense, so let's get straight to the point this time."

"The purpose of holding this press conference today is, of course, to introduce a new product I have developed, which is also the first blockbuster product since the establishment of Tianqi Pharmaceutical Company."

"It is called, Tianmu Eye Drops."

The large screen switched, and what appeared before everyone was an enlarged image of a reagent bottle, with some transparent liquid rippling inside.

This name made everyone immediately understand that the medicine Su Xin developed was indeed related to the eyes.

However, what kind of eye disease was it treating?

Myopia? Glaucoma? Blindness?

Various thoughts emerged in everyone's minds.

On the podium.

Su Xin used a PPT to display the sets of astonishing figures that Liu Guosong had mentioned earlier, allowing everyone to more clearly recognize the increasingly serious trend of myopia, its trend toward younger age groups, and the various social problems it brings.

Subsequently, he began to explain the principles and effects of Tianmu Eye Drops in coordination with the PPT.

"As is well known, myopia, hyperopia, and astigmatism are mainly problems of refractive error. Taking myopia patients as an example, the vast majority of people usually correct it by wearing myopia glasses."

"A small number of people choose surgery, which is also mainly laser surgery, polishing the cornea and forcibly changing the refractive system through external means to achieve the goal of correcting myopia."

"But you should know that this kind of myopia correction surgery not only carries the risk of failure but also has significant sequelae."

"And the Tianmu Eye Drops I developed are based on biotechnology, using biological agents processed from the metabolites of certain microorganisms to stimulate the eyeball, supplemented by appropriate eye massage, to allow the refractive system to automatically adjust and recover."

"The symptoms it can treat include myopia, hyperopia, astigmatism, and presbyopia."

"Moreover, it does not require incisions, does not require surgery, and does not forcibly change the structure of the eyeball through any external force; instead, it achieves the goal of correcting vision by stimulating the body's self-regulation function. There is no pain, no risk, and even less any sequelae."

Su Xin's words caused a wave of shock among the crowd.

Non-destructive Myopia Correction Technology sounds like a rather unremarkable technology, and myopia is not considered a major issue; even if the vast majority of people do not treat it, it will not have much impact on their lives.

However.

Considering the exaggerated number of myopia patients and the growth trend, the value of this technology is terrifying! It is even more valuable and meaningful than many technologies that sound high-end!

Those pharmaceutical companies, while shocked, secretly breathed a sigh of relief in their hearts.

Because there are no drugs on the market that treat myopia at all, the Tianmu Eye Drops developed by Su Xin do not have direct competition with any pharmaceutical company.

On the contrary, some executives in the eyewear industry who happened to be watching the live broadcast felt a bit panicked by the appearance of Tianmu Eye Drops.

Although the current effects of Tianmu Eye Drops are limited to Su Xin's verbal description and have not been verified by actual clinical trials, Su Xin has such a brilliant past record that no one dares to underestimate what he says.

And once what Su Xin says is true, it can be considered a devastating blow to the eyewear industry.

No wonder there is an old saying—

What defeats you is not your opponent, and what subverts you is not your peer, but cross-industry competition.

Who would have thought that the trillion-dollar global eyewear industry would suddenly face a challenge from a new entrant in the pharmaceutical industry?

Of course, the situation at this moment is not yet that severe; the eyewear industry has not yet felt the shock, and many people are even completely unaware of it.

On the podium.

After introducing the effects of Tianmu Eye Drops, Su Xin smiled and said:

"At present, the approval for this drug has been completed, and clinical trials will be conducted immediately. Starting tomorrow, we will recruit three batches of volunteers on our official website."

"At that time, we will publish all the progress of the clinical trials and welcome everyone's supervision."

After the product introduction, Su Xin introduced Nie Hongwu's identity to everyone, and then left the podium for the latter to speak.

After walking off the stage, Su Xin left the venue in a low-key manner and sent a message to Liu Guosong, arranging to meet him at a teahouse.

Half an hour later, in a private room of a teahouse.

Su Xin and Liu Guosong sat opposite each other.

Taking the initiative to pour a cup of clear tea for Liu Guosong, Su Xin smiled and said:

"Uncle, the Non-destructive Myopia Correction Technology has been successfully developed. It just so happens that I don't really want to open a pharmaceutical factory myself. I wonder if you are interested in cooperating?"

Liu Guosong smiled: "I couldn't ask for more!"

Of course, he knew that Su Xin's so-called lack of interest was just polite talk. Faced with a product with infinite prospects like Tianmu Eye Drops, who would be willing to give up the rich profits contained within?

It was nothing more than for the sake of Liu Xuewei that the other party would take the initiative to yield profits like this.

This made Liu Guosong feel great, and he was also full of gratitude toward Su Xin.

But in reality, what he did not know was that Su Xin really did not necessarily take the market prospects of Tianmu Eye Drops too much to heart, at least he did not take the profits of the production link too much to heart.

In Su Xin's view, for such a brand-new pharmaceutical product, if one wants to quickly open up the situation in the market, the simplest way is to cooperate with pharmaceutical companies, with himself providing the technology and the latter being responsible for production, channel sales, and terminal distribution.

It should be known that Tianmu Eye Drops only have a shelf life of two or three months in a Laboratory environment. During actual mass production, if changed to special packaging materials, the shelf life often has to be shortened even further.

This places extremely high demands on the two major links of the pharmaceutical company's sales channels and terminal distribution.

If Su Xin wants to spread Tianmu Eye Drops in the market as quickly as possible, the best solution is to lay out a sales network that covers the whole country.

To achieve this, even if Su Xin had tens of billions in funds and kept making big acquisitions, he might not be able to do it in a short time.

Therefore.

The best way is to cooperate with pharmaceutical companies, and to cooperate with multiple pharmaceutical companies at the same time.

Just like the Thor Battery and other major products, he provides the solution, and production and sales are left to the partners to execute, which is both convenient and can occupy the market as quickly as possible.

Now, he was merely handing one of the cooperation opportunities to Liu Guosong.

"Since that is the case, let us arrange for people to connect tomorrow and discuss the details of the cooperation."

"Very well, I wish us a pleasant cooperation!"

The two men's right hands clasped together, and smiles as gentle as a spring breeze appeared on their faces simultaneously.